Molecular Mechanisms Underlying Cardiac Protein Phosphatase 2A Regulation in Heart
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Kinase/phosphatase balance governs cardiac excitability in health and disease. Although detailed mechanisms for cardiac kinase regulation are established, far less is known regarding cardiac protein phosphatase 2A (PP2A) regulation. This is largely due to the complexity of the PP2A holoenzyme structure (combinatorial assembly of three subunit enzyme from >17 subunit genes) and the inability to segregate "global" PP2A function from the activities of multiple "local" holoenzyme populations. Here we report that PP2A catalytic, regulatory, and scaffolding subunits are tightly regulated at transcriptional, translational, and post-translational levels to tune myocyte function at base line and in disease. We show that past global read-outs of cellular PP2A activity more appropriately represent the collective activity of numerous individual PP2A holoenzymes, each displaying a specific subcellular localization (dictated by select PP2A regulatory subunits) as well as local specific post-translational catalytic subunit methylation and phosphorylation events that regulate local and rapid holoenzyme assembly/disassembly (via leucine carboxymethyltransferase 1/phosphatase methylesterase 1 (LCMT-1/PME-1). We report that PP2A subunits are selectively regulated between human and animal models, across cardiac chambers, and even within specific cardiac cell types. Moreover, this regulation can be rapidly tuned in response to cellular activation. Finally, we report that global PP2A is altered in human and experimental models of heart disease, yet each pathology displays its own distinct molecular signature though specific PP2A subunit modulatory events. These new data provide an initial view into the signaling pathways that govern PP2A function in heart but also establish the first step in defining specific PP2A regulatory targets in health and disease. Background: PP2A regulates cardiac excitability and physiology. Results: PP2A regulation in heart occurs through integrative transcriptional, translational, and post-translational control of three classes of subunits (17 genes) to control holoenzyme synthesis, localization, and maintenance; pathways are mechanistically altered in heart disease. Conclusion: Multiple mechanisms are present for acute and chronic regulation of specific PP2A populations. Significance: Results provide molecular insight into cardiac PP2A regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182456d46 · Cited by 1,512 · cited 1×
“First, we examined PP2A subunit expression after myocardial infarction (5 days after total coronary artery occlusion), a leading cause of death worldwide (42).”
MethodAnkyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death
Mohler, P. J., Schott, J.-J., Gramolini, A. O., Dilly, K. W., Guatimosim, S., duBell, W. H., Song, L.-S., Haurogné, K., Kyndt, F., Ali, M. E., et al. (2003) · Nature · doi:10.1038/nature01335 · Cited by 957
Self-citationRegulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation
Chen, J., Martin, B. L., & Brautigan, D. L. (1992) · Science · doi:10.1126/science.1325671 · Cited by 601
PP2A holoenzyme assembly: In cauda venenum (the sting is in the tail)
Janssens, V., Longin, S., & Goris, J. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.12.004 · Cited by 390 · cited 2×
“We examined the phosphorylation status of the catalytic subunit of PP2A at residueTyr-307, a site liked with inactivation of the phosphatase (10, 12, 46).”
BackgroundHemmings, B. A., Adams-Pearson, C., Maurer, F., Mueller, P., Goris, J., Merlevede, W., Hofsteenge, J., & Stone, S. R. (1990) · Biochemistry · doi:10.1021/bi00465a002 · Cited by 243
Sents, W., Ivanova, E., Lambrecht, C., Haesen, D., & Janssens, V. (2013) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08579.x · Cited by 204 · cited 1×
“We examined the phosphorylation status of the catalytic subunit of PP2A at residueTyr-307, a site liked with inactivation of the phosphatase (10, 12, 46).”
BackgroundLongin, S., Zwaenepoel, K., Louis, J. V., Dilworth, S., Goris, J., & Janssens, V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704059200 · Cited by 184
Overexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function
Gergs, U., Boknik, P., Buchwalow, I., Fabritz, L., Matus, M., Justus, I., Hanske, G., Schmitz, W., & Neumann, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405770200 · Cited by 125
Molecular basis for PP2A regulatory subunit B56α targeting in cardiomyocytes
Bhasin, N., Cunha, S. R., Mudannayake, M., Gigena, M. S., Rogers, T. B., & Mohler, P. J. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00059.2007 · Cited by 96
Self-citation
Cited by
Subcellular Organization of the cAMP Signaling Pathway
Zaccolo, M., Zerio, A., & Lobo, M. J. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000086 · Cited by 275
Protein phosphatase 2A regulatory subunit B56α limits phosphatase activity in the heart
Little, S. C., Curran, J., Makara, M. A., Kline, C. F., Ho, H.-T., Xu, Z., Wu, X., Polina, I., Musa, H., Meadows, A. M., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aaa5876 · Cited by 53
“The abundance of LCMT-1 and PME-1 was similar between genotypes (fig.”
BackgroundSelf-citationKirchhefer, U., Brekle, C., Eskandar, J., Isensee, G., Kučerová, D., Müller, F. U., Pinet, F., Schulte, J. S., Seidl, M. D., & Boknik, P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.598938 · Cited by 52
“B56 exhibits the highest expression in the heart and skeletal muscle (10, 11).”
BackgroundPPP2R5A: A multirole protein phosphatase subunit in regulating cancer development
Mao, Z., Liu, C., Lin, X., Sun, B., & Su, C. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.11.024 · Cited by 30
Metadata
- Authors
- DeGrande, S. T., Little, S. C., Nixon, D. J., Wright, P., Snyder, J., Dun, W., Murphy, N., Kilic, A., Higgins, R., Binkley, P. F., Boyden, P. A., Carnes, C. A., Anderson, M. E., Hund, T. J., & Mohler, P. J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 288
- Issue
- 2
- Pages
- 1032-1046
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1984128917
- Cited by
- 90
- References
- 13
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular Mechanisms Underlying Cardiac Protein Phosphatase 2A Regulation in Heart. https://app.cochat.ai/papers/10.1074/jbc.m112.426957
- The paper
- DeGrande, S. T., Little, S. C., Nixon, D. J., Wright, P., Snyder, J., Dun, W., Murphy, N., Kilic, A., Higgins, R., Binkley, P. F., Boyden, P. A., Carnes, C. A., Anderson, M. E., Hund, T. J., & Mohler, P. J. (2013). Molecular Mechanisms Underlying Cardiac Protein Phosphatase 2A Regulation in Heart. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m112.426957
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.